Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-22-039506

Chief Financial Officer bought 6,000 shares at an average $1.54 ($9,217)

From the SEC's structured data for this filing

Trades in this filing

Silver Brian M. · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-12-27 Purchase : show line 1 in the form +2,842 $1.50 $4,276 29,727 D
2022-12-28 Purchase : show line 2 in the form +3,158 $1.56 $4,941 32,885 D
Open-market purchases · 6,000 sh · avg $1.54 · $9,217
Loading xslF345X03/doc4.xml…